Annual Drug Patent Expirations for ANJESO
Anjeso is a drug marketed by Baudax and is included in one NDA. There are six patents protecting this drug.
Drug patent litigation for ANJESO.
This drug has forty-three patent family members in thirteen countries.
The generic ingredient in ANJESO is meloxicam. Additional details are available on the meloxicam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
